Patents by Inventor Maria De Los Angeles Vinuesa-Navarro

Maria De Los Angeles Vinuesa-Navarro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220177484
    Abstract: Compounds of general formula wherein the wavy bond ˜ is either a double bond or the epoxide, or pharmaceutically acceptable salts, solvates, tautomers, or stereoisomers thereof, for use in the treatment of diseases associated with oxidative stress.
    Type: Application
    Filed: March 12, 2020
    Publication date: June 9, 2022
    Applicant: INSTITUTO BIOMAR, S.A
    Inventors: Antonio FERNÁNDEZ MEDARDE, María de los Ángeles VINUESA NAVARRO, José María SÁNCHEZ LÓPEZ, Juan Pedro BOLAÑOS HERNÁNDEZ, María de los Ángeles ALMEIDA PARRA, Emilio FERNÁNDEZ SÁNCHEZ
  • Patent number: 10945443
    Abstract: A novel fungal strain of Tolypocladium album (synonym Chaunopycnis alba) is disclosed that has enhanced toxicity against insects and mites. This novel Tolypocladium album strain is capable of producing terpendoles A, C, I, J, K, N, O and P through fermentation and does not produce nalanthalide.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: March 16, 2021
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Maria de los Angeles Vinuesa Navarro, Jose Maria Sanchez Lopez, Deanna Branscome, Emily E. Brazil, Rebecca Dickenson, Daniel F. Heiman, Gary T. Wang, Zuoxing Zheng, Daniel C Leep
  • Publication number: 20190098904
    Abstract: A novel fungal strain of Tolypocladium album (synonym Chaunopycnis alba) is disclosed that has enhanced toxicity against insects and mites. This novel Tolypocladium album strain is capable of producing terpendoles A, C, I, J, K, N, O and P through fermentation and does not produce nalanthalide.
    Type: Application
    Filed: September 25, 2018
    Publication date: April 4, 2019
    Inventors: Maria de los Angeles Vinuesa Navarro, Jose Maria Sanchez Lopez, Deanna Branscome, Emily E. Brazil, Rebecca Dickenson, Daniel F. Heiman, Gary T. Wang, Zuoxing Zheng
  • Publication number: 20160152566
    Abstract: The invention refers to compounds of general formula (I) wherein the variables take the various meanings, pharmaceutical compositions containing them and their use in medicine. The compounds have shown to be useful in therapy as angiogenesis inhibitors. The compounds are isolated from the fermentation broth of a fungal strain Paraconiothyrium sp., or are derivatives thereof.
    Type: Application
    Filed: July 8, 2014
    Publication date: June 2, 2016
    Inventors: Antonio FERNÁNDEZ MEDARDE, Librada Maria CANEDO HERNÁNDEZ, María De Los Ángeles VINUESA-NAVARRO, José María SÁNCHEZ LÓPEZ, Belinda CALVO PELAZ, Marta MARTÍNEZ INSUA, Ana RODRÍGUEZ-QUESADA, Melissa CARCÍA-CABALLERO, Miguel-Ángel MEDINA-TORRES
  • Publication number: 20100184853
    Abstract: The present invention relates to the use of some terpenes, for example chlovalicin, ovalicin or fumagillin, as antifungal against Malassezia species and to their use in the manufacture of medicaments for the treatment of human skin diseases caused by these Malassezia species, such as pityriasis versicolor, seborrheic dermatitis, dandruff, atopic dermatitis, psoriasis, confluent and reticulated papillomatosis, onychomycosis, and transient acantholytic dermatosis.
    Type: Application
    Filed: June 13, 2008
    Publication date: July 22, 2010
    Applicant: INSTITUTO BIOMAR, S.A.
    Inventors: Librada Maria Canedo Hernandez, Maria De Los Angeles Vinuesa-Navarro, Antonio Fernandez-Medarde